SAN DIEGO, Sept. 9 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. , a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will be presenting at the following investment conferences:
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com in the Investor Relations section. A replay of each webcast will be available approximately three hours following the live webcasts and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever. For more information about Cadence’s pipeline, visit www.cadencepharm.com.
Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.
SOURCE Cadence Pharmaceuticals, Inc.
CONTACT: William R. LaRue, SVP, CFO of Cadence Pharmaceuticals, Inc.,
+1-858-436-1400
Web site: http://www.cadencepharm.com/
